_id
69147cdcccc777a4e85d913b
Ticker
MTEMQ
Name
MTEMQ
Exchange
NASDAQ
Address
9301 Amberglen Boulevard, Austin, TX, United States, 78729
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.mtem.com
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. On April 20, 2025, Molecular Templates, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Last Close
0.0001
Volume
416
Current Price
0.0001
Change
0
Last Updated
2025-12-26T13:19:59.125Z
Image
-
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-06-30
Revenue
189000
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
8485000
Operating Income
-8296000
Interest Expense
38000
Pretax Income
-8097000
Net Income
-8097000
Eps
-1.22982192871073
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
-4389.417989417989
Total Other Income Expense Net
107000
Cash
9657000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
12016000
Property Plant Equipment
13362000
Total Assets
26697000
Payables
2773000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
19586000
Equity
7111000
Depreciation
1046000
Change In Working Capital
547000
Cash From Operations
-5859000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
2757000
PE
-
PB
0.00009258725917592463
ROE
-113.86584165377585
ROA
-30.32925047758175
FCF
-5859000
Fcf Percent
-31
Piotroski FScore
1
Health Score
20
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1.5
Momentum Investing Score
3.5
Net Net Investing Score
2
Quality Investing Score
1
Value Investing Score
5
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
189000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
8485000
Quarters > 0 > income Statement > operating Income
-8296000
Quarters > 0 > income Statement > interest Expense
38000
Quarters > 0 > income Statement > pretax Income
-8097000
Quarters > 0 > income Statement > net Income
-8097000
Quarters > 0 > income Statement > eps
-1.22982192871073
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
6583880
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-4389.417989417989
Quarters > 0 > income Statement > total Other Income Expense Net
107000
Quarters > 0 > balance Sheet > cash
9657000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
12016000
Quarters > 0 > balance Sheet > property Plant Equipment
13362000
Quarters > 0 > balance Sheet > total Assets
26697000
Quarters > 0 > balance Sheet > payables
2773000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
19586000
Quarters > 0 > balance Sheet > equity
7111000
Quarters > 0 > cash Flow > net Income
-8097000
Quarters > 0 > cash Flow > depreciation
1046000
Quarters > 0 > cash Flow > change In Working Capital
547000
Quarters > 0 > cash Flow > cash From Operations
-5859000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
2757000
Quarters > 0 > ratios > PE
-1.22982192871073
Quarters > 0 > ratios > PB
0.00009258725917592463
Quarters > 0 > ratios > ROE
-113.86584165377585
Quarters > 0 > ratios > ROA
-30.32925047758175
Quarters > 0 > ratios > FCF
-5859000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-31
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
10924000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
10974000
Quarters > 1 > income Statement > operating Income
-50000
Quarters > 1 > income Statement > interest Expense
31000
Quarters > 1 > income Statement > pretax Income
572000
Quarters > 1 > income Statement > net Income
572000
Quarters > 1 > income Statement > eps
0.10643309935418181
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5374268
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-0.4577077993409008
Quarters > 1 > income Statement > total Other Income Expense Net
544000
Quarters > 1 > balance Sheet > cash
6779000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
10690000
Quarters > 1 > balance Sheet > property Plant Equipment
14931000
Quarters > 1 > balance Sheet > total Assets
27119000
Quarters > 1 > balance Sheet > payables
2681000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
21249000
Quarters > 1 > balance Sheet > equity
5870000
Quarters > 1 > cash Flow > net Income
572000
Quarters > 1 > cash Flow > depreciation
1122000
Quarters > 1 > cash Flow > change In Working Capital
-7509000
Quarters > 1 > cash Flow > cash From Operations
-5244000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-5244000
Quarters > 1 > ratios > PE
0.10643309935418181
Quarters > 1 > ratios > PB
0.00009155482112436116
Quarters > 1 > ratios > ROE
9.744463373083475
Quarters > 1 > ratios > ROA
2.1092223164570965
Quarters > 1 > ratios > FCF
-5244000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.48004393994873673
Quarters > 1 > health Score
40
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
6639000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
12010000
Quarters > 2 > income Statement > operating Income
-5371000
Quarters > 2 > income Statement > interest Expense
39000
Quarters > 2 > income Statement > pretax Income
-3959000
Quarters > 2 > income Statement > net Income
-3948000
Quarters > 2 > income Statement > eps
-0.7346116717662758
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
5374268
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-80.90073806296128
Quarters > 2 > income Statement > total Other Income Expense Net
1273000
Quarters > 2 > balance Sheet > cash
11523000
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
16772000
Quarters > 2 > balance Sheet > property Plant Equipment
16554000
Quarters > 2 > balance Sheet > total Assets
35383000
Quarters > 2 > balance Sheet > payables
1523000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
31171000
Quarters > 2 > balance Sheet > equity
4212000
Quarters > 2 > cash Flow > net Income
-3948000
Quarters > 2 > cash Flow > depreciation
1198000
Quarters > 2 > cash Flow > change In Working Capital
-3029000
Quarters > 2 > cash Flow > cash From Operations
-5287000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-5288000
Quarters > 2 > ratios > PE
-0.7346116717662758
Quarters > 2 > ratios > PB
0.00012759420702754037
Quarters > 2 > ratios > ROE
-93.73219373219374
Quarters > 2 > ratios > ROA
-11.157900686770484
Quarters > 2 > ratios > FCF
-5287000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.7963548727217955
Quarters > 2 > health Score
15
Quarters > 3 > quarter
2023-09-30
Quarters > 3 > income Statement > revenue
5732000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
10869000
Quarters > 3 > income Statement > operating Income
-5137000
Quarters > 3 > income Statement > interest Expense
31000
Quarters > 3 > income Statement > pretax Income
-4153000
Quarters > 3 > income Statement > net Income
-4153000
Quarters > 3 > income Statement > eps
-0.772756401429925
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5374268
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-89.61967899511515
Quarters > 3 > income Statement > total Other Income Expense Net
805000
Quarters > 3 > balance Sheet > cash
15811000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
22700000
Quarters > 3 > balance Sheet > property Plant Equipment
18245000
Quarters > 3 > balance Sheet > total Assets
44061000
Quarters > 3 > balance Sheet > payables
2583000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
37260000
Quarters > 3 > balance Sheet > equity
6801000
Quarters > 3 > cash Flow > net Income
-4153000
Quarters > 3 > cash Flow > depreciation
1507000
Quarters > 3 > cash Flow > change In Working Capital
-5359000
Quarters > 3 > cash Flow > cash From Operations
-7534000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
18384000
Quarters > 3 > cash Flow > net Change In Cash
10859000
Quarters > 3 > ratios > PE
-0.772756401429925
Quarters > 3 > ratios > PB
0.00007902173209822085
Quarters > 3 > ratios > ROE
-61.06454933098073
Quarters > 3 > ratios > ROA
-9.425569097387712
Quarters > 3 > ratios > FCF
-7534000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.3143754361479414
Quarters > 3 > health Score
15
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
52625000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
63091000
Annuals > 0 > income Statement > operating Income
-10466000
Annuals > 0 > income Statement > interest Expense
2654000
Annuals > 0 > income Statement > pretax Income
-8135000
Annuals > 0 > income Statement > net Income
-8124000
Annuals > 0 > income Statement > eps
-1.5116477257926102
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5374268
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-19.88788598574822
Annuals > 0 > income Statement > total Other Income Expense Net
3777000
Annuals > 0 > balance Sheet > cash
11523000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
16772000
Annuals > 0 > balance Sheet > property Plant Equipment
16554000
Annuals > 0 > balance Sheet > total Assets
35383000
Annuals > 0 > balance Sheet > payables
1523000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
31171000
Annuals > 0 > balance Sheet > equity
4212000
Annuals > 0 > cash Flow > net Income
-8124000
Annuals > 0 > cash Flow > depreciation
6645000
Annuals > 0 > cash Flow > change In Working Capital
-43770000
Annuals > 0 > cash Flow > cash From Operations
-41820000
Annuals > 0 > cash Flow > capital Expenditures
200000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-9116000
Annuals > 0 > cash Flow > net Change In Cash
-21841000
Annuals > 0 > ratios > PE
-1.5116477257926102
Annuals > 0 > ratios > PB
0.00012759420702754037
Annuals > 0 > ratios > ROE
-192.87749287749287
Annuals > 0 > ratios > ROA
-22.9601786168499
Annuals > 0 > ratios > FCF
-42020000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.798479809976247
Annuals > 0 > health Score
15
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
19754000
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
108625000
Annuals > 1 > income Statement > operating Income
-88871000
Annuals > 1 > income Statement > interest Expense
4716000
Annuals > 1 > income Statement > pretax Income
-92665000
Annuals > 1 > income Statement > net Income
-92718000
Annuals > 1 > income Statement > eps
-24.700632900769886
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
3753669
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-449.88863015085553
Annuals > 1 > income Statement > total Other Income Expense Net
-66000
Annuals > 1 > balance Sheet > cash
32190000
Annuals > 1 > balance Sheet > short Term Investments
28859000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
68298000
Annuals > 1 > balance Sheet > property Plant Equipment
25764000
Annuals > 1 > balance Sheet > total Assets
97548000
Annuals > 1 > balance Sheet > payables
504000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
36168000
Annuals > 1 > balance Sheet > total Liabilities
112680000
Annuals > 1 > balance Sheet > equity
-15132000
Annuals > 1 > cash Flow > net Income
-92718000
Annuals > 1 > cash Flow > depreciation
7383000
Annuals > 1 > cash Flow > change In Working Capital
-17193000
Annuals > 1 > cash Flow > cash From Operations
-89024000
Annuals > 1 > cash Flow > capital Expenditures
3198000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-265000
Annuals > 1 > cash Flow > net Change In Cash
6028000
Annuals > 1 > ratios > PE
-24.700632900769886
Annuals > 1 > ratios > PB
-0.00002480616574147502
Annuals > 1 > ratios > ROE
612.7279936558288
Annuals > 1 > ratios > ROA
-95.04859146266453
Annuals > 1 > ratios > FCF
-92222000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-4.668522830819074
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
38697000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
118771000
Annuals > 2 > income Statement > operating Income
-80074000
Annuals > 2 > income Statement > interest Expense
3369000
Annuals > 2 > income Statement > pretax Income
-83009000
Annuals > 2 > income Statement > net Income
-83009000
Annuals > 2 > income Statement > eps
-22.114096900925468
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3753669
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-206.92560146781403
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > balance Sheet > cash
24983000
Annuals > 2 > balance Sheet > short Term Investments
118061000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
148215000
Annuals > 2 > balance Sheet > property Plant Equipment
27917000
Annuals > 2 > balance Sheet > total Assets
192362000
Annuals > 2 > balance Sheet > payables
1612000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
35491000
Annuals > 2 > balance Sheet > total Liabilities
126700000
Annuals > 2 > balance Sheet > equity
65662000
Annuals > 2 > cash Flow > net Income
-83009000
Annuals > 2 > cash Flow > depreciation
6630000
Annuals > 2 > cash Flow > change In Working Capital
27901000
Annuals > 2 > cash Flow > cash From Operations
-30387000
Annuals > 2 > cash Flow > capital Expenditures
3996000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
92592000
Annuals > 2 > cash Flow > net Change In Cash
-235000
Annuals > 2 > ratios > PE
-22.114096900925468
Annuals > 2 > ratios > PB
0.00000571665346775913
Annuals > 2 > ratios > ROE
-126.418628735037
Annuals > 2 > ratios > ROA
-43.15249373576902
Annuals > 2 > ratios > FCF
-34383000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.8885184898054113
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
15635000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
116477000
Annuals > 3 > income Statement > operating Income
-100842000
Annuals > 3 > income Statement > interest Expense
1705000
Annuals > 3 > income Statement > pretax Income
-104911000
Annuals > 3 > income Statement > net Income
-104916000
Annuals > 3 > income Statement > eps
-31.484673593638966
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3332288
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-644.9760153501759
Annuals > 3 > income Statement > total Other Income Expense Net
-3392000
Annuals > 3 > balance Sheet > cash
25218000
Annuals > 3 > balance Sheet > short Term Investments
68667000
Annuals > 3 > balance Sheet > receivables
234000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
99384000
Annuals > 3 > balance Sheet > property Plant Equipment
33358000
Annuals > 3 > balance Sheet > total Assets
139877000
Annuals > 3 > balance Sheet > payables
2350000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
14926000
Annuals > 3 > balance Sheet > total Liabilities
80537000
Annuals > 3 > balance Sheet > equity
59340000
Annuals > 3 > cash Flow > net Income
-104916000
Annuals > 3 > cash Flow > depreciation
3917000
Annuals > 3 > cash Flow > change In Working Capital
1296000
Annuals > 3 > cash Flow > cash From Operations
-83797000
Annuals > 3 > cash Flow > capital Expenditures
7392000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
58895000
Annuals > 3 > cash Flow > net Change In Cash
-59565000
Annuals > 3 > ratios > PE
-31.484673593638966
Annuals > 3 > ratios > PB
0.000005615584765756656
Annuals > 3 > ratios > ROE
-176.80485338725987
Annuals > 3 > ratios > ROA
-75.0058980389914
Annuals > 3 > ratios > FCF
-91189000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-5.832363287496003
Annuals > 3 > health Score
24
Valuation > metrics > PE
-1.22982192871073
Valuation > metrics > PB
0.00009258725917592463
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
-113.86584165377585
Profitability > metrics > ROA
-67.38515312916113
Profitability > metrics > Net Margin
-42.84126984126984
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.7543242863169737
Risk > metrics > Interest Coverage
-218.31578947368422
Risk > final Score
-855
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.333213126577713
Liquidity > metrics > Quick Ratio
4.333213126577713
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
43
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
0
Prev Risks > 1
-545
Prev Risks > 2
-657
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:14:51.151Z
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. On April 20, 2025, Molecular Templates, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of MTEMQ
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.